Metformin can increase the sensitivity of ALL patients with high ABCB1 expression to chemotherapeutic drugs, reduce the recurrence rate, and increase the survival rate [51, 52]. This evidence concerns the gene ABCB1 and acute lymphoblastic leukemia.